Navigating Plaque Psoriasis Progress: A Year in Review

Saakshi Khattri, MD, and Mark Lebwohl, MD, share key insights on recent biologic, topical, and oral treatment approvals for the management of plaque psoriasis.

Experts in dermatology discuss the use of bimekizumab in clinical practice for plaque psoriasis as well as its off-label use.

Drs Mark Lebwohl and Saakshi Khattri review the significance of long-term data of bimekizumab for plaque psoriasis management.

Mark Lebwohl, MD, and Saakshi Khattri, MD, examine the use of spesolimab in various diseases, including generalized pustular psoriasis (GPP), and comment on the use and safety of deucravacitinib.

Expert dermatologists highlight the use of nonsteroidal topical therapies, roflumilast and tapinarof, for the management of plaque psoriasis.

Saakshi Khattri, MD, and Mark Lebwohl, MD, provide insight on the significance of steroid-free treatment options for the management of pediatric patients with plaque psoriasis and address unique considerations and challenges treating patients with skin of color.

Drs Mark Lebwohl and Saakshi Khattri review recent advancements and emerging therapies in development for plaque psoriasis treatment.

Experts in dermatology share closing thoughts on the management of plaque psoriasis.

Mark Lebwohl, MD, and Saakshi Khattri, MD, discuss the evolving landscape of plaque psoriasis treatments over the past year.